Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.

Scientific reports - 8 Jan 2021

Mukada Naoto, Tosaka Masahiko, Matsumura Nozomi, Yamaguchi Rei, Aihara Masanori, Isoda Koji, Higuchi Tetsuya, Tsushima Yoshito, Yokoo Hideaki, Yoshimoto Yuhei

Abstract excerpt

Papillary craniopharyngiomas are characterized by the BRAF V600E mutation. Enhancement of glucose metabolism may be involved in the downstream of the BRAF V600E mutation in many types of tumors. Glucose metabolism was investigated in craniopharyngioma using immunohistochemical analysis. The study included 29 cases of craniopharyngioma (18 adamantinomatous type [ACP], 11 papillary type [PCP]). Immunohistochemical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Craniopharyngioma
Share to Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose Transporter Type 1

Share to Hexokinase

Share to Immunochemistry

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 33420213
DOI: 10.1038/s41598-020-80259-4
PMCID: PMC7794328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.PMID 33420213Read ↗

[Etiology, Genetic Features and Clinical Presentations in Craniopharyngiomas].Semantic proximity Read ↗

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.Semantic proximity Read ↗

Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?Semantic proximity Read ↗

Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.Semantic proximity Read ↗

The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression.Semantic proximity Read ↗

Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosisSemantic proximity Read ↗

Expressions of GLUT-1, PK-M2 and HIF-1α and Mutation Status of BRAF in Odontogenic Keratocysts.Semantic proximity Read ↗

GLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva.Semantic proximity Read ↗

High‐resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomasSemantic proximity Read ↗

Craniopharyngioma: a case report and comparative galectin histochemical analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.